Skip to main content
Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · IEX Real-Time Price · USD
5.20
+0.03 (0.58%)
At close: May 31, 2024, 4:00 PM
5.26
+0.06 (1.15%)
After-hours: May 31, 2024, 7:55 PM EDT

Editas Medicine Revenue

Editas Medicine had revenue of $69.41M in the twelve months ending March 31, 2024, with 204.54% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.14M, a -88.48% decrease year-over-year. In the year 2023, Editas Medicine had annual revenue of $78.12M with 296.32% growth.

Revenue (ttm)
$69.41M
Revenue Growth
+204.54%
P/S Ratio
6.16
Revenue / Employee
$261,913
Employees
265
Market Cap
427.64M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202378.12M58.41M296.32%
Dec 31, 202219.71M-5.83M-22.83%
Dec 31, 202125.54M-65.19M-71.85%
Dec 31, 202090.73M70.20M341.93%
Dec 31, 201920.53M-11.41M-35.71%
Dec 31, 201831.94M18.21M132.64%
Dec 31, 201713.73M7.68M126.80%
Dec 31, 20166.05M4.42M271.58%
Dec 31, 20151.63M--
Dec 31, 20140--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bioventus 522.74M
biote 187.32M
Talkspace 162.13M
Theravance Biopharma 61.51M
Jin Medical International 19.82M
Ocugen 7.05M
Fate Therapeutics 6.48M
Oculis Holding AG 995.46K
Revenue Rankings

EDIT News

More News